Study evaluating how patients with Acute Coronary Syndrome are managed during 2 years after discharge - EPICOR
Study identifier:NIS-CEU-DUM-2009/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Long-term follow-up of antithrombotic management patterns in Acute Coronary Syndrome patients
Medical condition
ACS
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
10568
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Sept 2010
Primary Completion Date: 01 Mar 2013
Study Completion Date: 01 Mar 2013
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Sept 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|---|
| 1 Patients, older than 18, hospitalized within 24 hours of onset of symptoms and diagnosed with UA, STEMI or NSTEMI | - |
Contacts
Investigators
Principal Investigator
Mónica Tafalla
Medical Department.AstraZeneca Spain
